Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
life sciences
national blog main
san francisco blog main
san francisco top stories
2
×
acute migrane
amgen
bain capital
bausch health
boston blog main
boston top stories
breast cancer
cancer
cancer drugs
cobimetinib
deals
desmoid tumor
dihydroergotamine
dihydroergotamine mesylate
generic drug
glaxosmithkline
impel neuropharma
investing
ipo
medical device
migraine
multiple myeloma
national organization for rare disorders
national top stories
new york
new york blog main
new york top stories
nirogacestat
orbimed
ra capital
raleigh-durham blog main
raleigh-durham top stories
rare disease drugs
revolution medicines
What
drug
2
×
ipo
2
×
activity
biotech
cancer
companies
days
despite
dog
family
firm
hardest
hasn’t
hit
hottest
hunters
ipos
leading
line
medicines
migraine
pfizer
place
prep
proteins
ras
reels
research
revolution
satsuma
securing
slowed
spinout
springworks
stopped
summer
targets
Language
unset
Current search:
ipo
×
drug
×
" san francisco top stories "
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
